umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence
Show others and affiliations
2016 (English)In: Journal of Clinical Oncology, ISSN 0732-183X, E-ISSN 1527-7755, Vol. 34, no 2Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2016. Vol. 34, no 2
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:umu:diva-124002ISI: 000378109100055OAI: oai:DiVA.org:umu-124002DiVA: diva2:948457
Conference
Genitourinary Cancers Symposium, JAN 07-09, 2016, San Francisco, CA
Note

Supplement: S

Meeting Abstract: 55

Available from: 2016-07-12 Created: 2016-07-07 Last updated: 2016-07-12Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Stattin, Pär
By organisation
Urology and Andrology
In the same journal
Journal of Clinical Oncology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Total: 13 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf